By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher's pending $6.8 billion purchase of Beckman Coulter has cleared the last regulatory hurdle, the Washington-based conglomerate announced after the close of the market Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.